Company page

Kodiak Sciences Inc

Kodiak Sciences Inc, traded under the ticker KOD, is a public company based in the United States with a market capitalization of approximately $2.67 billion. The company focuses on developing innovative therapies for eye diseases. Kodiak is committed to advancing its research and product pipeline to address unmet medical needs in ophthalmology.